Skip to main content
medichelpline
Join Free
Back to Drug Index
General MedicationsORALGeneric

OMNIPEN (AMPICILLIN)

AMPICILLIN/AMPICILLIN TRIHYDRATE

Standard Dose
100MG/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued

Key Takeaways

  • Primary indication: Marketing status: Discontinued
  • Approval overview OMNIPEN (AMPICILLIN) is listed in Drugs@FDA under application 060625 (ANDA).
  • Marketing status: Discontinued Active ingredient AMPICILLIN/AMPICILLIN TRIHYDRATE Form and strength FOR SUSPENSION;ORAL - 100MG/ML Sponsor WYETH AYERST Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview OMNIPEN (AMPICILLIN) is listed in Drugs@FDA under application 060625 (ANDA). Marketing status: Discontinued Active ingredient AMPICILLIN/AMPICILLIN TRIHYDRATE Form and strength FOR SUSPENSION;ORAL - 100MG/ML Sponsor WYETH AYERST Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.